Martin A. Lehr

CIK: 0001861989

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CNTX

Context Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CNTX
Context Therapeutics Inc.
Feb 19, 2026
Award(A)
Stock Option (right to buy)
Direct
815K shares-
CNTX
Context Therapeutics Inc.
Jun 9, 2025
Purchase(P)
Indirect
100K shares at avg. $0.70$70K
CNTX
Context Therapeutics Inc.
Feb 13, 2025
Award(A)
Stock Option (right to buy)
Direct
802.7K shares-

		Type	Shares	Price		Ownership
Feb 19, 2026	CNTX Context Therapeutics Inc.	Award(A) Stock Option (right to buy)	815,000	-	-	Direct
Jun 9, 2025	CNTX Context Therapeutics Inc.	Purchase(P)	100,000	$0.70	$70,080	Indirect
Feb 13, 2025	CNTX Context Therapeutics Inc.	Award(A) Stock Option (right to buy)	802,700	-	-	Direct

1-3 of 3 transactions

About Lehr Martin A.

Lehr Martin A. (SEC CIK 0001861989) files insider reports with the SEC as Chief Executive Officer of Context Therapeutics Inc. (CNTX).

Signal8 holds 3 ownership filings by Lehr Martin A., all Form 4s, filed between Feb 14, 2025 and Feb 23, 2026. Those filings report 3 transactions, from Feb 13, 2025 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lehr Martin A.'s filings is in PHILADELPHIA, PA.

Recent filings by Lehr Martin A.

Feb 19, 2026: Grant or award of CNTX derivative securities (Form 4, code A).
Jun 9, 2025: Open-market purchase of CNTX shares (Form 4, code P).
Feb 13, 2025: Grant or award of CNTX derivative securities (Form 4, code A).

Other insiders filing for Context Therapeutics Inc. (CNTX)

Pasternak Andy, Director
Stacey Jennifer Evans, Director
West Linda, Director
Smith Karen L., Director
Walker Luke Nathaniel, Director
Kantoff Philip W., Director

How to read Form 4 transaction codes